Free Trial

Liquidia Technologies (LQDA) Competitors

Liquidia Technologies logo
$22.45 +0.00 (+0.02%)
As of 10:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LQDA vs. STVN, IRTC, BLCO, GKOS, TMDX, NVST, LIVN, SLNO, WRBY, and INSP

Should you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Soleno Therapeutics (SLNO), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Liquidia Technologies vs. Its Competitors

Stevanato Group (NYSE:STVN) and Liquidia Technologies (NASDAQ:LQDA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Stevanato Group has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500.

Liquidia Technologies has a consensus price target of $32.11, suggesting a potential upside of 43.01%. Given Liquidia Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Liquidia Technologies is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.83
Liquidia Technologies
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
3.00

In the previous week, Liquidia Technologies had 3 more articles in the media than Stevanato Group. MarketBeat recorded 7 mentions for Liquidia Technologies and 4 mentions for Stevanato Group. Liquidia Technologies' average media sentiment score of 0.90 beat Stevanato Group's score of 0.59 indicating that Liquidia Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Liquidia Technologies
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.15B7.14€127.45M€0.5450.00
Liquidia Technologies$14M138.08-$130.39M-$1.70-13.21

64.5% of Liquidia Technologies shares are held by institutional investors. 30.1% of Liquidia Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Stevanato Group has a net margin of 11.73% compared to Liquidia Technologies' net margin of -732.17%. Stevanato Group's return on equity of 10.34% beat Liquidia Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.73% 10.34% 6.21%
Liquidia Technologies -732.17%-232.96%-60.81%

Summary

Liquidia Technologies beats Stevanato Group on 9 of the 17 factors compared between the two stocks.

Get Liquidia Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LQDA vs. The Competition

MetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.92B$3.13B$5.72B$10.39B
Dividend YieldN/A2.36%5.53%4.58%
P/E Ratio-13.1020.9776.1626.62
Price / Sales138.08254.61471.8492.08
Price / CashN/A46.3537.4661.85
Price / Book24.679.8313.336.46
Net Income-$130.39M-$52.73M$3.29B$271.49M
7 Day Performance-10.18%4.18%2.29%2.97%
1 Month Performance-16.34%5.73%4.44%7.56%
1 Year Performance121.88%18.32%75.18%30.09%

Liquidia Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LQDA
Liquidia Technologies
3.9348 of 5 stars
$22.45
+0.0%
$32.11
+43.0%
+126.1%$1.92B$14M-13.1050
STVN
Stevanato Group
N/A€26.21
-0.8%
N/A+37.5%€7.94B€1.19B48.545,521
IRTC
iRhythm Technologies
1.1094 of 5 stars
$176.16
-2.0%
$163.82
-7.0%
+150.5%$5.78B$657.23M-60.122,000Positive News
Analyst Forecast
BLCO
Bausch + Lomb
1.9382 of 5 stars
$15.23
+0.2%
$15.56
+2.2%
-22.4%$5.38B$4.79B-19.5213,500
GKOS
Glaukos
4.5598 of 5 stars
$80.72
-2.5%
$124.83
+54.6%
-33.9%$4.75B$383.48M-48.92780Analyst Forecast
TMDX
TransMedics Group
2.2994 of 5 stars
$114.29
-0.2%
$122.11
+6.8%
-24.4%$3.91B$441.54M59.22210
NVST
Envista
3.7752 of 5 stars
$21.12
+0.5%
$20.92
-0.9%
+9.5%$3.49B$2.51B65.9912,300Positive News
LIVN
LivaNova
2.9111 of 5 stars
$55.43
-1.4%
$59.71
+7.7%
+5.2%$3.07B$1.25B-14.252,900Positive News
SLNO
Soleno Therapeutics
4.4441 of 5 stars
$51.17
-4.6%
$115.09
+124.9%
+18.1%$2.85BN/A-12.3630Gap Up
WRBY
Warby Parker
1.5988 of 5 stars
$26.37
-1.4%
$24.06
-8.8%
+95.6%$2.81B$771.32M-376.723,780
INSP
Inspire Medical Systems
4.8394 of 5 stars
$80.90
+1.1%
$164.50
+103.3%
-64.5%$2.37B$802.80M46.761,246Analyst Downgrade

Related Companies and Tools


This page (NASDAQ:LQDA) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners